A Clinical Research Study for
Moderate-to-Severe Eczema Is Enrolling.

It’s time
for more options
to treat eczema.

It’s time
for more options
to treat eczema.

The Advanta study for moderate-to-severe eczema is enrolling today!

Those who qualify may receive:
  • • Study-related care at no cost from local doctors
  • • Oral investigational study drug or placebo at no cost
  • • Compensation for time and travel
No health insurance or referrals needed.

Take the next step to see if you qualify for the Advanta study for people with Eczema.

But don’t delay — space is limited!

Take the next step to see if
you may qualify for the Zen study.

But don’t delay — space is limited!

Eczema, also known as atopic dermatitis,
is not just a cosmetic disease.

Eczema is a chronic skin condition that causes patches of red, itchy, dry skin to appear on various parts of the body. Its physical impact can have emotional repercussions.

Eczema, also known as atopic dermatitis,
is not just a cosmetic disease.

Moderate-to-severe eczema can interfere with everyday life, leading to stress in relationships and causing you to lose sleep, miss social activities, and be absent from work. Red, inflamed patches on visible areas of the body such as the face, neck, and hands may cause self-consciousness and embarrassment.

Eczema, also known as atopic dermatitis,
is not just a cosmetic disease.

TResearch studies help advance medicine for people in the United States and around the world. By volunteering for the Advanta study today, you could contribute to the potential development of an effective and safe treatment for moderate-to-severe eczema that may one day be available to all. Join the fight against this widespread skin condition.

Act now to see if you may qualify!

How does the online screener work?

Answer some questions about your health

Tell us a little
bit about yourself

Connect to an available
study in your area

Just takes a few minutes

AcurianHealth helps connect people with research studies that offer treatment under development.
Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.

Terms of Use/Privacy Policy

©2023 Acurian, Inc. All rights reserved.